Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473030 · ClinicalTrials.gov registry record
Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue
A clinical trial, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 80
- Enrollment target
NCT01473030 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 80 participants.
The verdict
NCT01473030 has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The overall goal of this project is to quantify the long-term effects of dutasteride on the architectural and nuclear features of benign prostate tissue, using state-of-the art digital image analysis techniques. The ultimate result will be a multivariable morphological "signature" that could provide a useful indicator of an individual's degree of drug response.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-11 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01473030
The ClinicalTrials.gov registry entry for NCT01473030 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01473030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01473030 about?
NCT01473030 is a clinical study titled "Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue". The overall goal of this project is to quantify the long-term effects of dutasteride on the architectural and nuclear features of benign prostate tissue, using state-of-the art digital image analysis techniques. The ultimate result will be a multivariable morphological "signature" that could provide...
What is the current status of trial NCT01473030?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2011-11. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01473030?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.